culture of organ-specific blood vascular and lymphaticendothelial cells of the mouse Takashi Yamaguchi, Taeko Ichise, Osamu Iwata, Akiko Hori, Tomomi Adachi, Masaru Nakamura, Nobuaki Yos
Trang 1culture of organ-specific blood vascular and lymphatic
endothelial cells of the mouse
Takashi Yamaguchi, Taeko Ichise, Osamu Iwata, Akiko Hori, Tomomi Adachi, Masaru Nakamura, Nobuaki Yoshida and Hirotake Ichise
Laboratory of Gene Expression and Regulation, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Japan
As an indispensable component of the vascular system,
endothelial cells (ECs) have pivotal roles in
develop-ment and in health and disease [1] Their properties
have been studied by a combination of in vitro
analy-ses of human primary ECs and in vivo analyanaly-ses of
genetically modified mice exhibiting vascular
pheno-types Human primary ECs are well-established
resources and are suitable for studying signal transduc-tion and cellular physiology in vitro However, it is still difficult to control their gene expression strictly by current overexpression and knockdown procedures In addition, they are not representative of all types of ECs at various developmental stages and in vascular beds [2] On the other hand, the use of genetically
Keywords
Cre ⁄ loxP recombination; endothelial cell
culture; endothelial heterogeneity; SV40
tsA58 large T antigen; transgenic mouse
Correspondence
H Ichise, Laboratory of Gene Expression
and Regulation, Center for Experimental
Medicine, Institute of Medical Science,
University of Tokyo, 4-6-1 Shirokanedai,
Minato-ku, Tokyo 108-8639, Japan
Fax: +81 3 5449 5455
Tel: +81 3 5449 5754
E-mail: h-ichise@ims.u-tokyo.ac.jp
(Received 27 November 2007, revised 13
February 2008, accepted 22 February 2008)
doi:10.1111/j.1742-4658.2008.06353.x
Endothelial cells are indispensable components of the vascular system, and play pivotal roles during development and in health and disease Their properties have been studied extensively by in vivo analysis of genetically modified mice However, further analysis of the molecular and cellular phe-notypes of endothelial cells and their heterogeneity at various developmen-tal stages, in vascular beds and in various organs has often been hampered
by difficulties in culturing mouse endothelial cells In order to overcome these difficulties, we developed a new transgenic mouse line expressing the SV40 tsA58 large T antigen (tsA58T Ag) under the control of a binary expression system based on Cre⁄ loxP recombination tsA58T Ag-positive endothelial cells in primary cultures of a variety of organs proliferate con-tinuously at 33C without undergoing cell senescence The resulting cell population consists of blood vascular and lymphatic endothelial cells, which could be separated by immunosorting Even when cultured for two months, the cells maintained endothelial cell properties, as assessed by expression of endothelium-specific markers and intracellular signaling through the vascular endothelial growth factor receptors VEGFR–2 and VEGFR-3, as well as their physiological characteristics In addition, lym-phatic vessel endothelial hyaluronan receptor-1 (Lyve-1) expression in liver sinusoidal endothelial cells in vivo was retained in vitro, suggesting that an organ-specific endothelial characteristic was maintained These results show that our transgenic cell culture system is useful for culturing murine endo-thelial cells, and will provide an accessible method and applications for studying endothelial cell biology
Abbreviations
BEC, blood vascular endothelial cell; DiI, 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate; EC, endothelial cell; ESC, embryonic stem cell; HRP, horseradish peroxidase; LDL, low-density lipoprotein; LEC, lymphatic endothelial cell; Lyve-1, lymphatic vessel endothelial hyaluronan receptor-1; MACS, magnetic-activated cell separation; MAPK, mitogen-activated protein kinase; PFA,
paraformaldehyde; Prox-1, prospero-related homeobox-1; SV40T Ag, SV40 large T antigen; tsA58T Ag, large T antigen of SV40 mutant strain tsA58; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor.
Trang 2modified mice has accelerated the understanding of
genetic mechanisms of endothelial development and
functions However, further analyses of vascular
phe-notypes in vivo have been hampered by the
compli-cated relationship between ECs and non-ECs such as
mural, hematopoietic and mesenchymal fibroblast cells,
even though a conditional genetic modification such as
endothelium-specific knockouts can provide a partial
solution to this problem Therefore, the isolation and
maintenance of murine endothelial cells from various
developmental stages and locations is important for
dissecting molecular and cellular mechanisms of
endo-thelial development and function
Murine primary cells, including ECs, have a more
limited growth potential than human primary cells
Thus, ‘immortalization’ techniques have been strongly
recommended for most analyses that require a large
quantity of transcripts, proteins or cells For
immortal-ization of ECs, viral oncogenic proteins have been
used in previous studies The polyoma middle T
anti-gen (PyMT Ag) allows selective proliferation of ECs in
mixed-cell populations [3–5], aiding in analyses of
genetically modified ECs in vitro [6–11] However,
PyMT Ag causes endothelioma or hemangioma in vivo
[3] and mimics activated receptor tyrosine kinases [12],
which might obscure the analysis of endogenous
recep-tor-mediated signaling Alternatively, tsA58T Ag, a
mutated SV40T Ag leading to temperature-dependent,
cell-type-independent cell proliferation [13,14], has
been used for ‘conditional immortalization’ of ECs of
wild-type and genetically modified mice [15–22]
Despite the fact that tsA58T Ag-directed
immortaliza-tion of ECs has been demonstrated, the method has
been under-utilized due to the specialized techniques
and expertise that are required for immunological
iso-lation of ECs [23,24] to prevent proliferation of
tsA58T Ag-expressing non-ECs
Results and Discussion
Generation of a transgenic mouse line carrying
the CAG-bgeo-tsA58T Ag transgene
In order to circumvent the problems described above,
we developed a new transgenic mouse line expressing
tsA58T Ag under the control of a binary expression
system based on Cre⁄ loxP recombination To obtain a
transgenic mouse line with the potential to express
tsA58T Ag in a variety of tissues including ECs, we
exploited embryonic stem cell (ESC)-mediated
trans-genesis Briefly, we constructed a transgene driven by
the CAG promoter [25] that expresses the b–geo gene
[26] in the absence of Cre recombinase, but expresses
the tsA58T Ag gene after Cre-mediated excision of the lox P-flanked b–geo gene (Fig 1) The plasmid vector-free transgene was introduced into ESCs, and G418-resistant clones were selected We next per-formed 5-bromo-4-chloro-3-indolyl-b-d-galactopyrano-side (X-gal) staining of embryoid bodies derived from each clone and screened for the expression pattern of b–geo in the embryoid bodies Clone T26 had the most favorable b–geo expression pattern among the G418-resistant clones (data not shown) tsA58T Ag expres-sion in ESCs after Cre-mediated exciexpres-sion was verified
by Western blotting (data not shown) The T26 genic mouse line was obtained through germline trans-mission from chimeric mice They grew normally, were fertile, and did not display any defects
Endothelium-specific expression of tsA58T Ag
in the transgenic mouse
We next crossed female T26 transgenic mice with male Tie2–Cre transgenic mice [27], which removed a loxP-flanked DNA fragment in endothelial cells and
T26 Tg
T26/Tie2-Cre Tg
Tie2-Cre Tg
tsA58T Ag-expressing endothelial cell
pA
loxP loxP
pA tsA58T CAG
tsA58T CAG
Enzymatic digestion of organs Culture at 33 °C
at split ratio 1 : 3
day 20–30 day 0
βgeo
Fig 1 An endothelial cell culture scheme based on endothelium-specific expression of tsA58T antigen pA, polyadenylation signal sequence; Tg, transgenic mouse.
Trang 3hematopoietic cells (Fig 1) The resulting T26⁄ Tie2–
Cre double-transgenic mice were born and grew
normally, but died suddenly within 6–12 weeks after
birth To determine whether the expression of tsA58T
Ag was induced in ECs, we performed
immunohisto-chemistry using antibodies against the pan-EC mar-ker, CD31, the lymphatic endothelial and liver sinusoidal endothelial marker Lyve-1 (lymphatic vessel endothelial hyaluronan receptor-1) [28–32] and SV40T
Ag Immunostaining revealed that tsA58T Ag was
A
C
B
SV40TCD31 SV40T Lyve-1
SV40TCD31
SV40TCD31
Fig 2 Expression pattern of tsA58T Ag in T26 ⁄ Tie2–Cre double-transgenic mice (A) tsA58T Ag (red) was expressed in CD31-positive ECs (green) of an E9.5 T26 ⁄ Tie2–Cre double-transgenic embryo and its yolk sac (B) tsA58T Ag (red) was expressed in CD31-positive ECs (green, left panels) and Lyve-1-positive ECs (green, right panels) of 3 )6-week-old T26 ⁄ Tie2–Cre double-transgenic mice Lyve-1-positive ECs were not detected in the brain (top right), which is known to be an LEC-free organ (C) tsA58T Ag (red) was also expressed in non-endothelial cells
of the thymic medulla and interstitial cells of the cardiac valve Arrowheads indicate CD31-positive ECs (green) All micrographs are shown
at the same magnification Scale bar = 50 lm.
Trang 4expressed in CD31-positive ECs of E9.5 embryos
proper and yolk sacs (Fig 2A) Postnatally, tsA58T
Ag was not only expressed in CD31-positive ECs in
the brain, heart, lung, liver and uterus (Fig 2B), but
was also expressed in Lyve-1-positive lymphatic
endo-thelial cells (LECs) in the heart, lung and uterus, and
sinusoidal ECs in the liver of 3–6-week-old
double-transgenic mice (Fig 2B), indicating that
endothe-lium-specific expression of tsA58T Ag was achieved
as expected Despite the mortality of the young
dou-ble-transgenic mice, no gross abnormalities, such as
endothelial hyperplasia, dysplasia or bleeding, could
be found in live or dead double-transgenic mice
However, immunostaining revealed that tsA58T Ag
was expressed in non-ECs, including a subset of
thy-mocytes and cardiac valvular cells (Fig 2C) These
observations are comparable to those of previous
studies using the same Tie2–Cre transgenic mouse
line, which showed that recombination occurred in
hematopoietic cells as well as ECs [27], and that
cardiac valvular cells were derived from endothelial
cells through an endothelial-to-mesenchymal
transi-tion during early development [33] The presence of
these cells may cause a dysfunctional cardiac flow
and cause the sudden death of the transgenic mice,
although it remains to be determined whether T
anti-gen-expressing cardiac valves are functionally affected
Endothelial cell culture from organs of
T26/Tie2–Cre double-transgenic mice
Following the demonstration of endothelium-specific
expression of tsA58T Ag in vivo, we performed primary
cell culturing (Fig 1) Several organs (the brain, heart,
lung, liver and uterus) were obtained from 3-week-old
T26 single- or T26⁄ Tie2–Cre double-transgenic mice,
dissected, and dissociated by enzymatic digestion
Dis-persed cell suspensions were plated onto gelatin-coated
plastic dishes and cultured at 33C (day 0 in Fig 1)
For the initial 2 weeks, primary cells, including both
tsA58T Ag-negative cells (primarily fibroblasts) and
tsA58T Ag-positive cells, proliferated, and ECs could
barely be morphologically distinguished However,
tsA58T Ag-negative cells gradually stopped
proliferat-ing and underwent senescence at about 2 weeks, as
assessed by morphology (data not shown) In contrast,
the remaining cells continued to proliferate over the
2 weeks and formed colonies that were distinguishable
under light-field microscopy (data not shown) tsA58T
Ag-negative senescent cells were progressively excluded
by serial passages At day 30, the dishes consisted
almost exclusively of viable tsA58T Ag-positive cells
(Figs 1 and 3A) Cells obtained from T26
single-trans-genic mice did not grow beyond 2–3 weeks (data not shown), confirming that tsA58T Ag-directed prolifera-tion was only achieved by Cre-mediated excision
Characterization of tsA58T Ag-expressing endothelial cell populations
In order to examine whether the tsA58T Ag-positive cells maintained EC properties, we first performed immunocytochemistry for EC markers and assessed the uptake of acetylated low-density lipoproteins (LDLs) The cell populations derived from the brain, lung, heart, liver and uterus stained positive for CD31 (Fig 3B for the brain, liver and uterus; data not shown for the lung and heart), strongly suggesting that the tsA58T Ag-posi-tive cells originated from ECs A subset of the cell popu-lations from the lung and heart (data not shown) and a
Brain
DAPI
A
B
C
D
tsA58T Ag Merge
Fig 3 Endothelial cell culture from organs of T26 ⁄ Tie2–Cre dou-ble-transgenic mice (A) Proliferating cells obtained from the brain were immunostained for SV40T Ag Proliferating cells without undergoing senescence were tsA58T Ag-positive DAPI, 4,6-diami-dino-2-phenylindole (B,C) Immunostaining revealed that tsA58T Ag-positive proliferating cells obtained from each organ maintained expression of the endothelial-specific markers CD31 (B) and Lyve-1 (C) (D) 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine per-chlorate (DiI)-labeled acetylated LDLs are taken up by these cells Bar = 50 lm (D, right panel) or 200 lm (all other panels).
Trang 5substantial proportion of the cell population from the
uterus (Fig 3C) also stained positive for Lyve-1,
indi-cating that cell populations obtained from these tissues
were a mixture of blood vascular ECs (BECs) and
LECs DiI-labeled acetylated LDLs were taken up by
all types of cell populations (Fig 3D for brain and
uter-ine ECs; data not shown for others), but not by
non-endothelial NIH3T3 cells (data not shown), indicating
that the cells maintained the physiological characteristic
of acetylated-LDL uptake
Lyve-1-positive liver sinusoidal endothelial cells
in vitro
Intriguingly, almost all of the cell population from the
liver were also positive for Lyve-1 (Fig 3C), and
Wes-tern blot analysis revealed that they were
Lyve-1-posi-tive, prospero-related homeobox-1 (Prox-1)-negative
[34] ECs (Fig 4B), suggesting that the population
rep-resented Lyve-1-positive liver sinusoidal ECs [30–32]
and maintained the property of Lyve-1 expression
in vitro These results also suggest that Lyve-1
expres-sion in liver sinusoidal ECs, reported as a marker of
differentiated organ-specific ECs [32] and a potential
diagnostic marker of liver cancer and cirrhosis [30], is
regulated in a cell-autonomous manner and is
irrevers-ible in the culture conditions used in this study These
cultured ECs might allow us to investigate more
prop-erties of liver sinusoidal ECs in health and disease
Isolation and characterization of BECs and LECs
We next isolated LECs from the mixed cell population
by magnetic immunosorting using an antibody against
Lyve-1 (Fig 4A) We used uterine ECs for this purpose
because they contained large numbers of
Lyve-1-posi-tive cells as assessed by immunostaining (Fig 3C) and
further confirmed by double staining for Lyve-1 and
another lymphatic endothelial marker, Prox-1 [34]
(Fig 4A) As shown by the immunostaining of
posi-tively sorted or depleted cells (Fig 4A), Lyve-1-positive
ECs were enriched as expected Western blot analysis revealed that Prox-1 and vascular endothelial growth factor receptor 3 (VEGFR-3), which is expressed pre-dominantly in LECs [35,36], were also expressed in Lyve-1-positive ECs (Fig 4B), confirming that LECs were obtained from the mixed EC population
tsA58T Ag-positive BECs and LECs transduced signals of endothelial growth factors
We further examined whether isolated ECs constitu-tively expressing tsA58T Ag could respond to angiogenic and lymphangiogenic growth factors Serum-depleted LECs were treated with vascular endo-thelial growth factors A or C (VEGF-A or VEGF-C) (Fig 4C) Phosphorylation of VEGFR-2 and mitogen-activated protein kinases (MAPKs), but not of VEGFR-3, was induced by VEGF-A, whereas phos-phorylation of VEGFR-2, VEGFR-3 and MAPKs was induced by VEGF-C, as reported in a previous study using human primary LECs [36] These results suggest that growth factor signals were transduced properly via endothelium-specific receptors in these cells Mes-enteric BECs and LECs (Fig 5A,B) were also obtained
by the same strategy as illustrated in Figs 1 and 4, and were treated with VEGF-A or VEGF-C (Fig 5C) MAPK and Akt phosphorylation were induced in both BECs and LECs by stimulation with VEGF-A or VEGF-C, indicating that the cultured ECs responded
to the endothelial growth factors
Implications for tube formation-based assays and transfection assays of tsA58T Ag-expressing ECs
We also examined whether the cells formed tube-like structures on collagen gel Both uterine BECs and LECs could form tube-like structures (Fig 4D) In addition, an SV40-ori-containing plasmid carrying a GFP expression cassette could be introduced by lipo-fection and maintained for at least 5 days after trans-fection as assessed by GFP expression (Fig 4E) These
Fig 4 Isolation and characterization of uterine BECs and LECs expressing tsA58T Ag (A) Scheme for sorting of LECs from the uterine EC population (days 30–40) A substantial proportion of uterine ECs were positive for Lyve-1 and Prox-1 (red and green on the top panel, respec-tively), indicating that the uterine EC population was a mixed cell population of BECs and LECs Lyve-1-positive LECs were isolated from mixed ECs by magnet immunosorting using anti-Lyve-1 antibody Scale bars ¼ 200 nm (B) Western blotting revealed that Lyve-1-positive uterine ECs maintained expression of Lyve-1, Prox-1 and VEGFR-3, indicating that they represent LECs In contrast, liver ECs were positive for Lyve-1 but not for Prox-1, indicating that they represent liver sinusoidal ECs (C) The uterine LECs transduced growth-factor signals via VEGFR-2 and VEGFR-3 IP, immunoprecipitation; IB, immunoblot; P-Y, phosphotyrosine (D) The uterine BECs and LECs formed tube-like structures Bars = 200 lm (E) SV40-ori-positive plasmids bearing GFP and drug-resistance genes were maintained in the uterine BECs and LECs for at least 5 days after transfection under drug-selection pressure Bars = 200 lm All cells were cultured at 33 C, and day 40–50 ECs were used for experiments shown in B–E.
Trang 6250kDa
IP: VEGFR-3 IB: P-Y
IP: VEGFR-3 IB: VEGFR-3
IB: P-VEGFR-2
IB: P-MAPK
IB: MAPK IB: VEGFR-2
No treatment VEGF-C VEGF-A
LECs
LECs
BECs
Brain ECs Heart ECs Liver ECs Lung ECs Uterine ECs (unsorted) Uterine ECs (Lyve-1+) Uterine ECs (Lyve-1–)
Lyve-1
Prox-1
VEGFR-3
tsA58 T Ag
/ tublin
Magnetic
A
B
C
D
E
immunosorting using anti-Lyve-1 Ab Uterine ECs
Positive Negative
BECs
Trang 7results suggest that these cells can not only be used in
functional analyses based on tube-like formation, but
also used in gain-of-function, knockdown or rescue
analyses using expression vectors
Taken together, these results demonstrate that
tsA58T Ag-positive BECs and LECs can be isolated
by a simple method using our transgenic system and
maintained at 33C without overt alterations in
endo-thelial properties, including specific gene expression,
physiological functions and intracellular signaling
Thus, our system provides an accessible method to
examine the endothelial cell biology of the mouse, and
will accelerate the molecular and cellular analysis of
ECs and their heterogeneity in various vascular beds
The early mortality of the T26⁄ Tie2–Cre double-transgenic mice is a disadvantage for the generation of T26⁄ Tie2–Cre double-transgenic mice with a mutation
in a gene-of-interest In addition, non-ECs expressing tsA58T Ag derived from Tie2-expressing hematopoietic cells and embryonic endothelial cells may be contami-nants in the present culture system In order to overcome these disadvantages, the use of tamoxifen-inducible Cre-expressing mice, such as the VE–cadherin–CreERT2 mice [37], may be preferable Homozygous T26 trans-genic mice may also facilitate production of these animals, although it remains to be determined whether the homozygous mice are viable and fertile
Experimental procedures Mice
C57BL⁄ 6J mice and MCH:ICR mice were purchased from CLEA Japan (Tokyo, Japan) Tie2–Cre transgenic mice (B6.Cg-Tg(Tek-cre)12Flv⁄ J, #004128) [27] were purchased from the Jackson Laboratory (Bar Harbor, ME, USA) All mice were housed under pathogen-free conditions All of the work with mice conformed to guidelines approved by the Institutional Animal Care and Use Committee of the University of Tokyo
Construction of the transgene Total RNA was extracted using TRIzol (Invitrogen, Carls-bad, CA, USA) from COS-7 cells harboring the wild-type SV40T Ag gene (purchased from Health Science Research Resources Bank, Osaka, Japan) The RNA was reverse-tran-scribed using SuperScript II (Invitrogen) and used for clon-ing the SV40T Ag cDNA The cDNA encodclon-ing the wild-type SV40T Ag and the 3¢ portion of the tsA58T Ag cDNA carry-ing the A438V mutation were PCR-amplified from COS-7 cDNAs using the following primers: LTA-1F, 5¢-CTC GAGATGGATAAAGTTTTAAACAGAG-3¢ and LTA-1R, 5¢-TGAAGGCAAATCTCTGGAC-3¢ for the former, and LTA–M2F, 5¢-CAGCTGTTTTGCTTGAATTATG-3¢ and LTA–2R, 5¢-GAATTCATTATGTTTCAGGTTCA GGGG-3¢ for the latter The PCR products were cloned into the EcoRV site of pZErO-2 (Invitrogen) A XhoI–PvuII-digested fragment of the wild-type SV40T Ag cDNA and a PvuII–EcoRI-digested fragment of the ts58T Ag cDNA were re-ligated and subcloned into XhoI–EcoRI-digested pZErO-2 and sequence-verified The pCGX vector was constructed by replacing the EcoRI–HindIII fragment of pCAGGS [25] (kindly provided by J.-I Miyazaki, Osaka University, Japan) with the following fragments: b–geo cDNA with the poly-adenylation signal sequence of the bovine growth hormone gene derived from pSA–bgeo [26] (kindly provided by
H Niwa, RIKEN Center for Developmental Biology,
No treatment No treatment VEGF-A VEGF-C
p-MAPK
MAPK
p-Akt
Akt BECs LECs
BECs
C
LECs CD31
SV40T
Lyve-1
SV40T
BECs LECs Prox-1
VEGFR-3
Lyve-1
Fig 5 Isolation and characterization of mesenteric BECs and LECs
expressing tsA58T Ag Mesenteric ECs were obtained from an
8-week-old T26 ⁄ Tie2–Cre double-transgenic mouse as illustrated in
Fig 1 (A) CD31-positive, Lyve-1-negative BECs and CD31-positive,
Lyve-1-positive LECs expressing tsA58T Ag were separated by
magnetic immunosorting using anti-Lyve-1 antibody by the method
illustrated in Fig 4A Red, Lyve–1 and CD31; green, SV40T Ag.
Bar = 200 lm (B) Prox–1 and VEGFR–3 were also expressed in
Lyve–1-positive ECs, confirming that they maintained lymphatic
endothelial properties (C) VEGF–A and VEGF–C induced MAPK and
Akt activation in both populations of mesenteric ECs Day 30–40
endothelial cells were cultured at 33 C and used in (B) and (C).
Trang 8Kobe, Japan), two synthetic lox P sequences and cloning
sites, a polyadenylation signal sequence of the mouse Pgk
gene derived from pGT-N28 (NEB, Ipswich, MA, USA),
and a portion of the multiple cloning site derived from
pMCS5 (MoBiTec, Goettingen, Germany) Briefly, the lox
P-flanked b–geo cassette was cloned under the control of
the CAG promoter, followed by several cloning sites
including a SwaI site, polyadenylation signal sequence of
the Pgk gene, and a portion of the multiple cloning site
of pMCS5 XhoI–EcoRI-digested tsA58T Ag cDNA was
blunted and cloned into the SwaI site of pCGX, and
the direction was verified by enzymatic digestion and
sequencing
Generation of a transgenic mouse line carrying
the CAG–b–geo–tsA58T Ag transgene
SalI-digested pCGX harboring the tsA58T Ag cDNA was
resolved by electrophoresis, and a plasmid vector-free
fragment was electro-eluted, phenol-extracted,
ethanol-pre-cipitated, and dissolved in NaCl⁄ Pi A 10 lg aliquot of
the transgene was introduced into E14.1 ESCs by
electro-poration ESCs expressing the transgene were selected by
incubation for 7 days in medium containing a
concentra-tion of G418 (Invitrogen) of 400 lgÆmL)1 G418-resistant
colonies were picked and expanded for PCR genotyping
and the formation of embryoid bodies One ESC clone
(T26) out of 48 G418-resistant clones was further
exam-ined for the presence of the tsA58T cDNA expression unit
and for widespread expression of b–geo in embryoid
bodies To validate binary expression of the transgene, a
plasmid vector harboring CAG–Cre (kindly provided by
I Saito, Institute of Medical Science, University of
Tokyo, Japan) was introduced into T26 ESCs by
electro-poration The resulting b–geo-free subclones (T26d) were
selected and propagated for Western blot analysis of the
SV40T Ag
For production of transgenic mice, T26 ESCs were
injected into B6 blastocysts The resulting blastocysts were
transplanted into the uterus of pseudo-pregnant MCH:ICR
female mice Chimeric male mice were then crossed with B6
female mice T26 transgenic mice were back-crossed five
times or more with B6 mice and used for analysis For
genotyping, PCR and⁄ or X-gal staining of tail tips were
performed
ESCs were maintained on a layer of irradiated,
G418-resistant mouse primary embryonic fibroblasts in
high-glucose (4.5 gÆL)1) Dulbecco’s modified Eagle’s medium
supplemented with 15% fetal bovine serum, 0.1 mm
2-mer-captoethanol and a culture supernatant of leukemia
inhibi-tory factor (LIF)-producing BMT10 cells (kindly provided
by J I Miyazaki, Osaka University, Japan) Embryoid
bodies were obtained by culturing ESCs in the medium not
supplemented with LIF-conditioned medium on non-coated
dishes
Immunohistochemistry and immunocytochemistry Embryos and tissues were collected, fixed in 4% parafor-maldehyde (PFA) overnight at 4C, processed in NaCl ⁄ Pi
containing 20% sucrose, and embedded in OCT (optimum cutting temperature) compound (Sakura Finetec, Tokyo, Japan) Sections (10–15 lm) of several tissues were cut using a cryotome (Sakura Finetech) The sections were mounted onto Matsunami adhesive silane-coated slides (Matsunami, Osaka, Japan) and dried overnight at room temperature The dried specimens were rehydrated in NaCl⁄ Pi and then antigen-retrieved for the detection of SV40T Ag by incubation in NaCl⁄ Pi containing 0.1– 0.25% trypsin and 0.5 mm EDTA at 37C or room tem-perature for 10–25 min Prior to incubation with primary antibodies, all sections were incubated in NaCl⁄ Pi or methanol containing 3% H2O2 at room temperature for 10–15 min The primary antibodies used in this study were
as follows: anti-PECAM-1 (BD Pharmingen, Franklin Lakes, NJ, USA), anti-Lyve-1 (R&D, Minneapolis, MN, USA), anti-Prox-1 (Acris Antibodies, Hiddenhausen, Germany), and anti-SV40 T Ag (Santa Cruz Biotechnol-ogy, Santa Cruz, CA, USA) The corresponding secondary antibodies labeled with horseradish peroxidase (HRP) (Biosource, Invitrogen), AlexaFluor 488 or AlexaFluor 546 (Molecular Probes, Invitrogen) were used Alternatively, Histofine (Nichirei Biosciences, Tokyo, Japan) was used For double immunostaining using HRP-conjugated anti-bodies for both of the secondary antianti-bodies, sections stained with the first primary and secondary antibody were incubated in NaCl⁄ Pi containing 3% H2O2 at room temperature for 15 min prior to incubation with the second primary antibody The signal-enhancing TSA Plus fluorescence system (Perkin-Elmer, Waltham, MA, USA) for HRP-conjugated secondary antibodies was also used for visualization 4,6-diamidino-2-phenylindole (Molecular Probes) was used for nuclear staining Fluorescent micro-scopic photographs were acquired using an Olympus IX70 microscope with DP70 imaging system (Olympus, Tokyo, Japan)
For immunocytochemistry, cells were fixed on ice with 4% PFA in NaCl⁄ Pifor 10 min, incubated in methanol at )20 C for 20 min, and rehydrated in NaCl ⁄ Pi For detec-tion of Prox-1, cells were further bleached and the TSA Plus fluorescence system was used For the detection of other proteins, AlexaFluor-conjugated secondary antibodies were used for visualization
Western blot analysis Cell lysates (40 lg, or 20 lg for lysates from cells shown
in Fig 5) were loaded, resolved by SDS–PAGE, and wet- or semi-dry-blotted onto poly(vinylidene difluoride)
Trang 9membranes (Bio-Rad, Hercules, CA, USA) Western blot
anal-ysis was performed using the following primary antibodies:
goat anti-Lyve-1 polyclonal IgG (1 : 500; Santa Cruz),
rab-bit anti-Prox-1 polyclonal IgG (1 : 500; Upstate⁄ Millipore,
Billerica, MA, USA), rat anti-VEGFR-3 monoclonal IgG
(AFL4, 1 : 500; eBioscience, San Diego, CA, USA), rat
anti-VEGFR-2 monoclonal IgG (Avas2a, 1 : 500;
eBio-science), rabbit phospho-VEGFR-2 monoclonal IgG
(1 : 1000; Cell Signaling Technology, Danvers, MA, USA),
rabbit anti-SV40 large T antigen polyclonal IgG (1 : 1000;
Santa Cruz), rabbit anti-a⁄ b-tubulin polyclonal IgG
(1 : 1000; Cell Signaling Technology), rabbit
anti-phospho-p42⁄ 44 MAPK polyclonal IgG (1 : 1000, Cell Signaling
Technology), rabbit anti-p42⁄ 44 MAPK polyclonal IgG
(1 : 1000, Cell Signaling Technology), rabbit anti-phospho–
Akt polyclonal IgG (1 : 1000, Cell Signaling Technology)
and anti-Akt polyclonal IgG (1 : 1000, Cell Signaling
Technology) The secondary antibodies were swine
anti-goat IgG (HRP) (1 : 1000; Biosource), anti-goat anti-rabbit IgG
(HRP) (1 : 1000; Cell Signaling Technology or GE
Health-care, Piscataway, NJ, USA; 1 : 2000 used for the detection
of rabbit primary antibodies purchased from Cell
Signal-ing Technology), and goat anti-rat IgG (HRP) (1:1000;
Biosource) Skim milk (5%) in Tris-buffered saline
con-taining 0.05-0.1% Tween 20 was used for blocking
non-specific antibody binding Antibody-labeled bands were
visualized using an enhanced chemiluminescence kit (GE
Healthcare) and X-ray film (Fujifilm, Tokyo, Japan)
To detect phosphorylated tyrosine residues in
VEGFR-3, rabbit anti-VEGFR-3 polyclonal IgG (Santa Cruz) and
protein G (Calbiochem⁄ Merck, Darmstadt, Germany)
were used for immunoprecipitation Blocking One-P
(Nakarai-tesque, Kyoto, Japan) was used for blocking
The membranes were incubated with mouse
anti-phos-photyrosine monoclonal IgG (4G10, 1 : 2000; Upstate) at
4C overnight, followed by incubation with sheep
anti-mouse IgG (HRP) (1 : 4000; GE Healthcare)
at room temperature for 1 h ‘Can Get Signal’ solution
(Toyobo, Osaka, Japan) was used for dilution of both
antibodies
Cell culture and isolation of lymphatic endothelial
cells from an endothelial-cell population
Tissues were collected, washed in NaCl⁄ Pi, and dissociated
by agitation in Hanks’ balanced salt solution containing
0.2% type IV collagenase or NaCl⁄ Pi containing 0.1%
trypsin for 30–60 min at 37C After pipetting the solution
containing digested tissues several times, the
enzyme-con-taining buffer was thoroughly removed by centrifugation
and washing several times with NaCl⁄ Pi Dissociated cells
were filtered through a 100 lm nylon mesh to remove
undissociated tissues, and cultured in microvascular
endothelial cell medium 2 (EGM-2MV) (Lonza, Basel,
Switzerland) at 33C, the permissive temperature for
tsA58T Ag The initial cells attached to dishes were passaged when sub-confluent to remove dead cells and small pieces of tissues Confluent cells were usually pas-saged every 2–3 days at a split ratio of 1 : 3, but several passages around day 20 were performed without splitting because tsA58T-negative cells had undergone senescence, decreasing the cell number
Isolation of Lyve-1-positive endothelial cells was per-formed using magnetic immunosorting Magnetic-activated cell separation (MACS) columns and MACS goat anti-rat IgG microbeads (Miltenyi Biotec, Bergisch Galdbach, Germany) were used according to the manufacturer’s pro-tocol Attached cells were trypsinized, collected and counted Cells (1· 107) were resuspended with 50 lL of MACS buffer containing 50 lgÆmL)1 antibody against Lyve-1 (MAB2125, R&D) and incubated on ice for 5–10 min The primary antibody-labeled cells were washed twice with 500–1000 lL MACS buffer, resuspended in
100 lL MACS buffer containing microbeads, and incu-bated on ice for 15 min Following a rinse with MACS buf-fer, the cells were suspended with 500 lL MACS buffer and applied onto MACS columns Magnetically selected positive cells and depleted cells were cultured independently
as lymphatic endothelial cells and blood vascular endothe-lial cells, respectively
Prior to activation with growth factors, cells were cul-tured in endothelial cell basal medium 2 (EBM-2) basal medium (Cambrex) without either serum or supplemental growth factors for 16–18 h Recombinant human VEGF-A (Peprotech EC, London, UK) or rat VEGF-C (R&D) was added to EBM medium at a final concentration of
100 ngÆmL)1 Cells were then incubated at 33C for 20 min and harvested for analysis
For the experiment shown in Fig 5, mesenteric endo-thelial cells were isolated by the method described above with slight modification Prior to treatment with growth factors, cells were cultured in EBM-2 basal medium with 0.5% serum for 24 h Cells were incubated with growth factors at 33C for 10 min and harvested for analysis
Tube formation of tsA58T-expressing endothelial cells on collagen gel
Matrigel (9.5 mgÆmL)1; BD Pharmingen) was placed into 24-well dishes, and 2–4· 104 endothelial cells were seeded
on the Matrigel and cultured for 24 h at 33C
Uptake of DiI-labeled acetylated LDL into tsA58T-expressing endothelial cells DiI-labeled acetylated LDL was added to the culture med-ium at a final concentration of 10 lgÆmL)1, and the cells were incubated at 37C overnight Dishes were washed with NaCl⁄ Pi and observed by fluorescent microscopy
Trang 10NIH3T3 cells (Health Science Research Resources Bank,
Osaka, Japan) were used as a negative control
Transfection of plasmids harboring a
GFP-expressing cassette into
tsA58T-expressing endothelial cells
Transfection was performed using Lipofectamine LTX and
pcDNA6.2-GW ⁄ miR-neg control plasmid (Invitrogen)
according to the manufacturer’s protocol GFP signals were
used to assess transfection and expression of the plasmid
Acknowledgements
We thank Dr Jun-ichi Miyazaki (Osaka University,
Japan) for providing pCAGGS, pCAG-LIF and
BMT10 cells; Dr Hitoshi Niwa (RIKEN Center for
Developmental Biology, Kobe, Japan) for providing
pSA-bgeo; Dr Izumo Saito (Institute of Medical
Science, University of Tokyo, Japan) for providing
pCAG-Cre; Dr Ikuo Yana (Institute of Medical
Science, University of Tokyo, Japan) for help in
per-forming endothelial tube formation experiments This
work was supported by grants from the Japan Society
for the Promotion of Science (to T I.) and the
Minis-try of Education, Culture, Sports, Science and
Tech-nology, Japan (to T Y., T I., N Y and H I.)
References
1 Adams RH & Alitalo K (2007) Molecular regulation of
angiogenesis and lymphangiogenesis Nat Rev Mol Cell
Biol 8, 464–478
2 Aird WC (2007) Phenotypic heterogeneity of the
endo-thelium: I Structure, function, and mechanisms Circ
Res 100, 158–173
3 Williams RL, Courtneidge SA & Wagner EF (1988)
Embryonic lethalities and endothelial tumors in
chime-ric mice expressing polyoma virus middle T oncogene
Cell 52, 121–131
4 Garlanda C, Parravicini C, Sironi M, De Rossi M,
Wainstok de Calmanovici R, Carozzi F, Bussolino F,
Colotta F, Mantovani A & Vecchi A (1994)
Progressive growth in immunodeficient mice and
host cell recruitment by mouse endothelial cells
transformed by polyoma middle-sized T antigen:
implications for the pathogenesis of opportunistic
vascular tumors Proc Natl Acad Sci USA 91,
7291–7295
5 Balconi G, Spagnuolo R & Dejana E (2000)
Develop-ment of endothelial cell lines from embryonic stem cells:
a tool for studying genetically manipulated endothelial
cells in vitro Arterioscler Thromb Vasc Biol 20,
1443–1451
6 Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oostuyse B, Dewerchin M et al (1999) Targeted defi-ciency or cytosolic truncation of the VE-cadherin gene
in mice impairs VEGF-mediated endothelial survival and angiogenesis Cell 98, 147–157
7 Cattelino A, Liebner S, Gallini R, Zanetti A, Balconi
G, Corsi A, Bianco P, Wolburg H, Moore R, Oreda B
et al.(2003) The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility J Cell Biol 162, 1111–1122
8 Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom HC et al (2003) Endothelial PDGF–B retention is required for proper investment of pericytes in the microvessel wall Genes Dev 17, 1835–1840
9 Bazzoni G, Tonetti P, Manzi L, Cera MR, Balconi G
& Dejana E (2005) Expression of junctional adhesion molecule–A prevents spontaneous and random motility
J Cell Sci 118, 623–632
10 Pece-Barbara N, Vera S, Kathirkamathamby K, Liebner S, Di Guglielmo GM, Dejana E, Wrana JL & Letarte M (2005) Endoglin null endothelial cells prolif-erate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and
an activated Alk1 pathway J Biol Chem 280, 27800–27808
11 Rothermel TA, Engelhardt B & Sheibani N (2005) Polyoma virus middle–T-transformed PECAM–1 defi-cient mouse brain endothelial cells proliferate rapidly in culture and form hemangiomas in mice J Cell Physiol
202, 230–239
12 Ichaso N & Dilworth SM (2001) Cell transformation by the middle T–antigen of polyoma virus Oncogene 20, 7908–7916
13 Jat PS & Sharp PA (1989) Cell lines established by a temperature-sensitive simian virus 40 large-T–antigen gene are growth restricted at the nonpermissive temper-ature Mol Cell Biol 9, 1672–1681
14 Jat PS, Noble MD, Ataliotis P, Tanaka Y, Yannoutsos
N, Larsen L & Kioussis D (1991) Direct derivation of conditionally immortal cell lines from an H–2Kb–tsA58 transgenic mouse Proc Natl Acad Sci USA 88, 5096–5100
15 Kanda S, Landgren E, Ljungstrom M & Claesson-Welsh L (1996) Fibroblast growth factor receptor 1-induced differentiation of endothelial cell line estab-lished from tsA58 large T transgenic mice Cell Growth Differ 7, 383–395
16 Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, Frank D, Brownlee M, Flynn E, Parangi S et al (1997) Oncogenic H–ras stimulates tumor angiogenesis by two distinct pathways Proc Natl Acad Sci USA 94, 861–866